FLG expression is reduced in keratinocytes treated with proinflammatory cytokines and in skin lesions of patients with AD, suggesting that a characteristic of chronic inflammatory skin diseases is the reduced expression of FLG, an established genetic factor of chronic skin inflammation [9]. Here, FLG is linked to Alzheimer disease.